𝔖 Bobbio Scriptorium
✦   LIBER   ✦

N38 SENSITIVITY AND SPECIFICITY OF SERUM MARKER CA-125 IN PATIENTS WITH UROTHELIAL CARCINOMA

✍ Scribed by P.G. Yakovlev; V.S. Sakalo; V.V. Mrachkovskiy; A.V. Kondratenko; V.M. Hrygorenko; G.P. Olijnichenko

Book ID
119621886
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
590 KB
Volume
9
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

CA 125: A valid marker in ovarian carcin
CA 125: A valid marker in ovarian carcinoma patients treated with paclitaxel?
✍ Elvira M. Davelaar; Johannes M. G. Bonfrer; Rob A. Verstraeten; Wim W. ten Bokke πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 709 KB

## BACKGROUND. Changes in serum CA 125 from baseline do not reflect response to paclitaxel in relapsed ovarian carcinoma patients. Our study aimed to determine whether CA 125 changes relate to tumor response and overall survival during paclitaxel salvage treatment. ## METHODS. Response data and